Philina Lee - Mar 13, 2024 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Melissa Masse, Attorney-in-Fact
Stock symbol
BPMC
Transactions as of
Mar 13, 2024
Transactions value $
-$702,302
Form type
4
Date filed
3/15/2024, 04:47 PM
Previous filing
Mar 11, 2024
Next filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $4.6K +523 +1.28% $8.80 41.5K Mar 13, 2024 Direct
transaction BPMC Common Stock Options Exercise $18.4K +1.22K +2.95% $15.01 42.8K Mar 13, 2024 Direct
transaction BPMC Common Stock Sale -$563K -6.22K -14.56% $90.55 36.5K Mar 13, 2024 Direct F1
transaction BPMC Common Stock Sale -$162K -1.8K -4.93% $89.88 34.7K Mar 13, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.16 to $91.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2).
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $89.53 to $90.15.